FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

22 letters match. Newest first.

  1. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  2. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk
  3. Nature’s Elements, Inc.

    Nature's Elements sold supplement powders with disease claims as unapproved drugs and made them with no required manufacturing records, FDA says.

    High risk
  4. Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals

    FDA warned Cholrem over selling unapproved RemChol enema products with claims to treat atherosclerosis and reverse heart disease.

    High risk
  5. Curtis Jacquot dba Pacific BioLogic Co.

    Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.

    High risk
  6. Natural Relief Inc.

    Natural Relief Inc. of Coshocton, Ohio, sold two herbal capsule products as unapproved drugs and had serious supplement manufacturing violations.

    High risk
  7. Biorica International Corp.

    FDA warned Biorica International that its Plaquex Oral Dietary Supplement is an unapproved new drug because website claims promote disease treatment and prevention.

    High risk
  8. Osmosis, LLC

    Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.

    High risk
  9. Jackson Health & Wellness Clinic

    FDA warned Jackson Health & Wellness Clinic that website claims for Dr. Miller’s teas and supplements make them unapproved and misbranded drugs.

    Low
  10. Saffron USA LLC

    FDA warned Saffron USA that its tea and blend products are unapproved new drugs because website claims say they treat diseases.

    Low
  11. Essential Elements

    FDA says Essential Elements’ CholestAid supplement is an unapproved new drug and misbranded because website claims say it treats cholesterol and heart issues.

    Low
  12. iwi

    FDA warned iwi that its iwi Cholesterol supplement is an unapproved new drug because website claims say it lowers cholesterol.

    High risk
  13. BergaMet North America LLC

    FDA warned BergaMet North America that its Cholesterol Command supplement is an unapproved new drug and misbranded because of disease claims.

    High risk
  14. Chambers' Apothecary

    FDA warned Chambers' Apothecary that website claims make Blood Pressure Support and CoEnzyme Q10 unapproved new drugs.

    Low
  15. Anabolic Laboratories Inc

    FDA told Anabolic Laboratories its CoQ10 Ubiquinol Prime and Policosanol Microtabs supplements were unapproved new drugs because website claims promised disease treatment.

    Low
  16. Princess Lifestyles, LLC

    FDA warns Princess Lifestyles over unapproved drug claims, CGMP failures, and ephedrine-alkaloid supplement Stomaisu.

    High risk
  17. LIV Health LLC dba INFINIWELL and DEAL Media L.L.C. dba HARMONIA

    FDA warned LIV Health/INFINIWELL and DEAL Media/HARMONIA that seven products were sold as unapproved new drugs via disease-treatment claims.

    High risk
  18. Phytag Labs

    FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.

    Medium
  19. Phoenix Nutritionals, Inc.

    FDA warned Phoenix Nutritionals that disease-treatment claims on its supplement websites make eight products unapproved drugs, including COVID-19 claims.

    High risk
  20. Omega Wonders LLC.

    Omega Wonders LLC sells Cardia 7 and Tear Health supplements with disease claims, making them unapproved new drugs and misbranded.

    Low
  21. North American Hirudin Biotech Products Inc.

    FDA warned North American Hirudin Biotech Products that Hirudin and Red 65 are unapproved drugs sold with disease-treatment claims.

    High risk
  22. Entia Biosciences, Inc

    FDA warned Entia Biosciences over mushroom supplement website claims that made the products unapproved, misbranded drugs.

    Low